Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine therapy for progressive multiple sclerosis
2011-003775-11Phase 4Completed
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluoxetine in multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). Primary endpoint: Time to confirmed disease progression. Started Sep 2011; status: completed.
02
Drugs
fluoxetine
03
Conditions
multiple sclerosis (MS)primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on 2011-003775-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003775-11.